Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy

The rapidly expanding data sets derived from genomic and transcriptomic analyses have allowed greater understanding of structural and functional network patterns within the genome resulting in a realignment of thinking within a systems biologic framework of cancer. However, insofar as spatially and...

Full description

Bibliographic Details
Main Authors: Yuqiao Shen, Neil N. Senzer, John J. Nemunaitis M.D.
Format: Article
Language:English
Published: AboutScience Srl 2008-01-01
Series:Drug Target Insights
Online Access:https://doi.org/10.4137/DTI.S649
id doaj-a1f663eb7d5b4be7b436774d713797e3
record_format Article
spelling doaj-a1f663eb7d5b4be7b436774d713797e32020-11-25T03:40:28ZengAboutScience SrlDrug Target Insights1177-39282008-01-01310.4137/DTI.S649Use of Proteomics Analysis for Molecular Precision Approaches in Cancer TherapyYuqiao Shen0Neil N. Senzer1John J. Nemunaitis M.D.2LEAD Therapeutics, Inc., San Bruno, CA.Mary Crowley Cancer Research Centers, Dallas, TX.Mary Crowley Cancer Research Centers, Dallas, TX.The rapidly expanding data sets derived from genomic and transcriptomic analyses have allowed greater understanding of structural and functional network patterns within the genome resulting in a realignment of thinking within a systems biologic framework of cancer. However, insofar as spatially and temporally dynamic differential gene expression at the protein level is the mediate effector of cellular behavior and, in view of extensive post translational modification (PTM), the need for sensitive, quantitative, and high throughput proteomic analytic techniques has emerged. To circumvent the problems of tissue sample heterogeneity, laser capture microdissection (LCM) allows for the acquisition of homogeneous cell populations. Using different fluorescent dyes to label protein samples prior to gel electrophoresis, 2-D DIGE (two-dimensional differential in-gel electrophoresis) can, with reasonable sensitivity, process three protein samples on the same gel allowing for intragel relative quantification. MudPIT (multidimensional protein identification technology) is a non-gel approach exploiting the unique physical properties of charge and hydrophobicity which allows the separation of peptide mixtures as well as direct MS (mass spectrometry) and database searching. The introduction of iTRAQ (isobaric tags for relative and absolute quantification) achieves labeling of all peptides by employing an 8-plex set of amine reactive tags to derivatize peptides at the N-terminus and lysine side chains allowing for absolute quantification and assessment of PTM. These and other new laboratory technologies, along with improved bioinformatics tools, have started to make significant contributions in cancer diagnostics and treatments.https://doi.org/10.4137/DTI.S649
collection DOAJ
language English
format Article
sources DOAJ
author Yuqiao Shen
Neil N. Senzer
John J. Nemunaitis M.D.
spellingShingle Yuqiao Shen
Neil N. Senzer
John J. Nemunaitis M.D.
Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy
Drug Target Insights
author_facet Yuqiao Shen
Neil N. Senzer
John J. Nemunaitis M.D.
author_sort Yuqiao Shen
title Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy
title_short Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy
title_full Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy
title_fullStr Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy
title_full_unstemmed Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy
title_sort use of proteomics analysis for molecular precision approaches in cancer therapy
publisher AboutScience Srl
series Drug Target Insights
issn 1177-3928
publishDate 2008-01-01
description The rapidly expanding data sets derived from genomic and transcriptomic analyses have allowed greater understanding of structural and functional network patterns within the genome resulting in a realignment of thinking within a systems biologic framework of cancer. However, insofar as spatially and temporally dynamic differential gene expression at the protein level is the mediate effector of cellular behavior and, in view of extensive post translational modification (PTM), the need for sensitive, quantitative, and high throughput proteomic analytic techniques has emerged. To circumvent the problems of tissue sample heterogeneity, laser capture microdissection (LCM) allows for the acquisition of homogeneous cell populations. Using different fluorescent dyes to label protein samples prior to gel electrophoresis, 2-D DIGE (two-dimensional differential in-gel electrophoresis) can, with reasonable sensitivity, process three protein samples on the same gel allowing for intragel relative quantification. MudPIT (multidimensional protein identification technology) is a non-gel approach exploiting the unique physical properties of charge and hydrophobicity which allows the separation of peptide mixtures as well as direct MS (mass spectrometry) and database searching. The introduction of iTRAQ (isobaric tags for relative and absolute quantification) achieves labeling of all peptides by employing an 8-plex set of amine reactive tags to derivatize peptides at the N-terminus and lysine side chains allowing for absolute quantification and assessment of PTM. These and other new laboratory technologies, along with improved bioinformatics tools, have started to make significant contributions in cancer diagnostics and treatments.
url https://doi.org/10.4137/DTI.S649
work_keys_str_mv AT yuqiaoshen useofproteomicsanalysisformolecularprecisionapproachesincancertherapy
AT neilnsenzer useofproteomicsanalysisformolecularprecisionapproachesincancertherapy
AT johnjnemunaitismd useofproteomicsanalysisformolecularprecisionapproachesincancertherapy
_version_ 1724534598735495168